Potency determinations of acetylcholinesterase inhibitors using Ellman's reaction-based assay in screening: Effect of assay variants

Analytical Biochemistry

Volumn 408, Issue 1, 2011, Pages 166-168

  Järvinen, Päivi ^a   Vuorela, Pia ^b   Hatakka, Annele ^a   Fallarero, Adyary ^b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b ÅBO AKADEMI UNIVERSITY   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMISTRY; CHEMISTRY;

ACETYLCHOLINESTERASE; ACETYLCHOLINESTERASE INHIBITORS; DRUG DISCOVERY; INHIBITION MECHANISMS; MEASUREMENTS OF; REAGENT ADDITIONS; SCREENING ASSAYS; SUBSTRATE CONCENTRATIONS;

CARBONYL COMPOUNDS;

CHOLINESTERASE INHIBITOR; PHYSOSTIGMINE; REAGENT; TACRINE;

ARTICLE; BIOASSAY; DRUG DEVELOPMENT; DRUG POTENCY; DRUG SCREENING; PRIORITY JOURNAL;

EID: 77958449754     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2010.09.018     Document Type: Article

References (22)

1. Darreh-Shori T., Soininen H. Effects of cholinesterase inhibitors on the activities and protein levels of cholinesterases in the cerebrospinal fluid of patients with Alzheimer's disease: a review of recent clinical studies. Curr. Alzheimer Res. 2010, 7:67-73.
2. van Marum R.J. Current and future therapy in Alzheimer's disease. Fundam. Clin. Pharmacol. 2008, 22:265-274.
3. Macarron R., Hertzberg R.P. Design and implementation of high-throughput screening assays. Methods Mol. Biol. 2009, 565:1-32.
4. Ellman G.L., Courtney K.D., Andres V., Feather-Stone R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 1961, 7:88-95.
5. Lee I.K., Yun B.S. Highly oxygenated and unsaturated metabolites providing a diversity of hispidin class antioxidants in the medicinal mushrooms Inonotus and Phellinus. Bioorg. Med. Chem. 2007, 15:3309-3314.
6. Adsersen A., Kjolbye A., Dall O., Jager A.K. Acetylcholinesterase and butyrylcholinesterase inhibitory compounds from Corydalis cava Schweigg. & Kort. J. Ethnopharmacol. 2007, 113:179-182.
7. Tang H., Wei Y.B., Zhang C., Ning F.X., Qiao W., Huang S.L., Ma L., Huang Z.S., Gu L.Q. Synthesis, biological evaluation, and molecular modeling of oxoisoaporphine and oxoaporphine derivatives as new dual inhibitors of acetylcholinesterase/butyrylcholinesterase. Eur. J. Med. Chem. 2009, 44:2523-2532.
8. Järvinen P.P., Fallarero A., Gupta S., Mohan G.C., Hatakka A.I., Vuorela P.M. Miniaturization and validation of the Ellman's reaction based acetylcholinesterase inhibitory assay into 384-well plate format and screening of a chemical library. Comb. Chem. High Throughput Screen. 2010, 13:278-284.
9. Ingkaninan K., de Best M.C., van der Heijden R., Hofte A.J., Karabatak B., Irth H., Tjaden U.R., van der Greef J., Verpoorte R. High-performance liquid chromatography with on-line coupled UV, mass spectrometric, and biochemical detection for identification of acetylcholinesterase inhibitors from natural products. J. Chromatogr. A 2000, 872:61-73.
10. Oinonen P.P., Jokela J.K., Hatakka A.I., Vuorela P.M. Linarin, a selective acetylcholinesterase inhibitor from Mentha arvensis. Fitoterapia 2006, 77:429-434.
11. Atta-ur-Rahman, Parveen S., Khalid A., Farooq A., Choudhary M.I. Acetyl and butyrylcholinesterase-inhibiting triterpenoid alkaloids from Buxus papillosa. Phytochemistry 2001, 58:963-968.
12. Liston D.R., Nielsen J.A., Villalobos A., Chapin D., Jones S.B., Hubbard S.T., Shalaby I.A., Ramirez A., Nason D., White W.F. Pharmacology of selective acetylcholinesterase inhibitors: implications for use in Alzheimer's disease. Eur. J. Pharmacol. 2004, 486:9-17.
13. Nochi S., Asakawa N., Sato T. Kinetic study on the inhibition of acetylcholinesterase by 1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl]methylpiperidine hydrochloride (E2020). Biol. Pharm. Bull. 1995, 18:1145-1147.
14. Pietsch M., Christian L., Inhester T., Petzold S., Gutschow M. Kinetics of inhibition of acetylcholinesterase in the presence of acetonitrile. FEBS J. 2009, 276:2292-2307.
15. al-Jafari A.A. The nature of the inhibition of camel retina acetylcholinesterase (EC 3.1.1.7) activity by tetrahydroaminoacridine. J. Ocul. Pharmacol. Ther. 1996, 12:503-514.
16. Ogura H., Kosasa T., Kuriya Y., Yamanishi Y. Comparison of inhibitory activities of donepezil and other cholinesterase inhibitors on acetylcholinesterase and butyrylcholinesterase in vitro. Methods Find. Exp. Clin. Pharmacol. 2000, 22:609-613.
17. Silverman R. The Organic Chemistry of Drug Design and Drug Action 2004, 227-322. Academic Press, London. J. Hayhurst (Ed.).
18. Stojan J., Zorko M. Kinetic characterization of all steps of the interaction between acetylcholinesterase and eserine. Biochim. Biophys. Acta 1997, 1337:75-84.
19. 50) of an enzymatic reaction. Biochem. Pharmacol. 1973, 22:3099-3108.
20. Rhee I.K., van Rijn R.M., Verpoorte R. Qualitative determination of false-positive effects in the acetylcholinesterase assay using thin layer chromatography. Phytochem. Anal. 2003, 14:127-131.
21. Kang S.Y., Lee K.Y., Sung S.H., Park M.J., Kim Y.C. Coumarins isolated from Angelica gigas inhibit acetylcholinesterase: structure-activity relationships. J. Nat. Prod. 2001, 64:683-685.
22. Lv W., Xue Y. Prediction of acetylcholinesterase inhibitors and characterization of correlative molecular descriptors by machine learning methods. Eur. J. Med. Chem. 2010, 45:1167-1172.